S&P ASX All Technology

US Dollar vs AUD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

CLRB Cellectar Biosciences Inc

0.278

-0.033 (-10.61%)

11 Jan 2025 - Closed

Delayed by 15 minutes

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Cellectar Biosciences (NASDAQ:CLRB)
Historical Stock Chart
From Dec 2024 to Jan 2025

Click Here for more Cellectar Biosciences Charts.

Cellectar Biosciences (NASDAQ:CLRB)
Historical Stock Chart
From Jan 2024 to Jan 2025

Click Here for more Cellectar Biosciences Charts.

Cellectar Biosciences Inc News

Form 8-K - Current report
Thursday 12 December 2024 (1 month ago) • Edgar (US Regulatory)

Cellectar Biosciences Provides Strategic Update on Clinical Development, Pipeline Programs and Corporate Restructuring
Wednesday 11 December 2024 (1 month ago) • GlobeNewswire Inc.

Form 8-K - Current report
Monday 18 November 2024 (2 months ago) • Edgar (US Regulatory)

Cellectar Biosciences Reports Financial Results for Q3 2024 and Provides a Corporate Update
Monday 18 November 2024 (2 months ago) • GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Monday 18 November 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Saturday 16 November 2024 (2 months ago) • Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Friday 15 November 2024 (2 months ago) • Edgar (US Regulatory)

Cellectar Biosciences and NorthStar Medical Radioisotopes Announce Partnership for Supply of Actinium-225
Friday 15 November 2024 (2 months ago) • GlobeNewswire Inc.

Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB
Thursday 14 November 2024 (2 months ago) • Edgar (US Regulatory)

Cellectar Biosciences and SpectronRx Partner to Manufacture Novel Phospholipid Radioconjugate for the Treatment of Cancer
Wednesday 13 November 2024 (2 months ago) • GlobeNewswire Inc.

Cellectar Biosciences to Report Third Quarter Financial Results and Host a Conference Call on Monday, November 18, 2024
Tuesday 12 November 2024 (2 months ago) • GlobeNewswire Inc.

Cellectar Selected to Present New Data from Phase 2 CLOVER-WaM Study in Oral Session at ASH 2024
Thursday 7 November 2024 (2 months ago) • GlobeNewswire Inc.

More Cellectar Biosciences Inc News Articles

AUD vs US Dollar

Gold vs US Dollar

Australian SE All Ordina...

Invesco QQQ Trust Series 1

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions